000 01646 a2200469 4500
005 20250517090603.0
264 0 _c20170117
008 201701s 0 0 eng d
022 _a2326-6074
024 7 _a10.1158/2326-6066.CIR-15-0255
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYao, Jun
245 0 0 _aAltered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.
_h[electronic resource]
260 _bCancer immunology research
_c06 2016
300 _a552-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlternative Splicing
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aCytotoxicity, Immunologic
_xgenetics
650 0 4 _aDatabases, Genetic
650 0 4 _aEpithelial-Mesenchymal Transition
_xgenetics
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aMelanocytes
_xmetabolism
650 0 4 _aMelanoma
_xgenetics
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aPrognosis
650 0 4 _aRNA-Binding Proteins
_xgenetics
650 0 4 _aTranscriptome
700 1 _aCaballero, Otavia L
700 1 _aHuang, Ying
700 1 _aLin, Calvin
700 1 _aRimoldi, Donata
700 1 _aBehren, Andreas
700 1 _aCebon, Jonathan S
700 1 _aHung, Mien-Chie
700 1 _aWeinstein, John N
700 1 _aStrausberg, Robert L
700 1 _aZhao, Qi
773 0 _tCancer immunology research
_gvol. 4
_gno. 6
_gp. 552-61
856 4 0 _uhttps://doi.org/10.1158/2326-6066.CIR-15-0255
_zAvailable from publisher's website
999 _c25893242
_d25893242